U.S. regulators approved Bristol-Myers Squibb’s advanced lung cancer drug Opdivo, ithe latest of a string of events that has the oncology world riveted on efforts to enlist the body’s immune system to fight the disease.
via WSJ.com: US Business http://ift.tt/1NiJHaa
via WSJ.com: US Business http://ift.tt/1NiJHaa
Nessun commento:
Posta un commento